Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy - A randomized controlled trial

Metabolism: Clinical and Experimental

Volumn 50, Issue 4, 2001, Pages 414-417

  Katoh, Shuichi ^a,b,c   Hata, Shoichi ^a,b,c   Matsushima, Masato ^a,b,c   Ikemoto, Suguru ^a,b,c   Inoue, Yunosuke ^a,b,c   Yokoyama, Junichi ^a,b,c   Tajima, Naoko ^a,b,c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kawaguchi Municipal Medical Center   (Japan)

^c Inoue Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN; PLACEBO; SULFONYLUREA; TRIACYLGLYCEROL; TROGLITAZONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DYSLIPIDEMIA; FATTY LIVER; FEMALE; HEMOGLOBIN DETERMINATION; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0035053339     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.21691     Document Type: Article

References (20)

1. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects
2. Activators of peroxisome proliferator-activated receptor-γ have depot-specific effects on human preadipocyte differentiation
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (IKPDS 33)
4. Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women
5. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity
6. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women
7. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM
8. Morphologic changes associated with sulfonylurea therapy
9. Estimation of human body composition by electrical impedance methods: A comparative study
10. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
11. Guidelines for diabetes care, a desktop guide to type 2 diabetes mellitus
12. The relation of liver fat to computed tomography numbers: A preliminary experimental study in rabbits
13. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease
14. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
15. Long-term effects of oral hypoglycemic agents on fat distribution and glucose tolerance in OLETF rats
16. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats
17. Effect of troglitazone on body fat distribution in type 2 diabetic patients
18. Prevention of hyperglycemia in Zucker diabetic fatty rat by treatment with metformin or troglitazone
19. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes
20. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance